Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains
- 1 May 2016
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 231, 48-55
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Small Hydrophobic Protein of the Human Respiratory Syncytial Virus Forms Pentameric Ion ChannelsJournal of Biological Chemistry, 2012
- Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010Emerging Infectious Diseases, 2012
- Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or MotavizumabThe Journal of Infectious Diseases, 2011
- Palivizumab‐Resistant Human Respiratory Syncytial Virus Infection in InfancyClinical Infectious Diseases, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Human respiratory syncytial virus and other viral infections in infants receiving palivizumabJournal of Clinical Virology, 2008
- Function of the Respiratory Syncytial Virus Small Hydrophobic ProteinJournal of Virology, 2007
- In Vitro and In Vivo Fitness of Respiratory Syncytial Virus Monoclonal Antibody Escape MutantsJournal of Virology, 2006
- Surveillance of Clinical Isolates of Respiratory Syncytial Virus for Palivizumab (Synagis)–Resistant MutantsThe Journal of Infectious Diseases, 2004
- Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteinsVirus Research, 1994